Brady Olson, M.D.

Brady Olson, M.D., completed his undergraduate studies at the University of Wisconsin-Eau Claire, where he double majored in cellular and molecular biology and philosophy, complemented by a minor in chemistry — reflecting his passion for both scientific precision and thoughtful inquiry. While in college, he conducted ecological bioremediation research at the Charles Darwin Research Station in the Galapagos Islands, where he contributed efforts to eradicate an invasive species of fly — demonstrating an early commitment to applying research to solve real-world problems.

After graduation, Olson worked as an analytical chemist and microbiologist for the Eau Claire City-County Health Department, where he designed a qPCR assay to detect Lyme disease in local tick populations, advancing early diagnosis and treatment advocacy in his community.

He earned his medical degree from the University of Wisconsin-Madison, where he was actively involved in the ethics committee, and was awarded the prestigious Herman and Gwendolyn Shapiro Foundation Research Scholarship. His research at the Wisconsin Institute for Discovery focused on innovative CAR-T cell therapy targeting pediatric neuroblastoma, underscoring his dedication to pioneering treatments. Alongside his research, Olson volunteered at a clinic serving the unhoused, reinforcing his commitment to equitable care.

Olson completed his internal medicine residency at Harvard Medical School, where he served as a clinical fellow responsible for teaching future physicians. His special interests included population health and exploring the intersection of socioeconomic status and access to medical care — publishing a national study on foregone medical care among adults caring for chronically ill children. During his residency he gave a Harvard Medical School grand rounds presentation on his novel findings related to high flow nasal cannula therapy during the COVID-19 pandemic.

His fellowship in pulmonary and critical care at Dell Medical School at The University of Texas at Austin was marked by leadership, serving as co-chief fellow, a simulation lab leader and guest lecturer at the University of Massachusetts and Texas State School of Respiratory Therapy. He had significant scholarly contributions that covered a range of critical topics, including disseminated cryptococcus infections, chylothorax management, best practices for central line insertion, and emergent tracheostomy dislodgement management. Olson’s exceptional presentation skills earned him a national award from the American College of Chest Physicians.

Olson’s clinical philosophy centers around compassionate patient care, high-value, low-waste practices and mastery of complex procedures. He is a respected leader, trusted physician and dedicated to improving patient outcomes.